Research record: Real-world minimal residual disease assessment in multiple myeloma using a standardized flow cytometry approach: feasibility, clinical implications, and immune correlates from a single-center experience.
Published in Haematologica; first publication date 2026-09-03. PMID 42687806.
This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.